HealthCor Management as of March 31, 2019
Portfolio Holdings for HealthCor Management
HealthCor Management holds 48 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | 5.6 | $139M | 1.1M | 132.02 | |
| UnitedHealth (UNH) | 5.6 | $138M | 557k | 247.26 | |
| Zimmer Holdings (ZBH) | 5.5 | $136M | 1.1M | 127.70 | |
| Medtronic (MDT) | 5.4 | $134M | 1.5M | 91.08 | |
| Neurocrine Biosciences (NBIX) | 5.4 | $134M | 1.5M | 88.10 | |
| Haemonetics Corporation (HAE) | 4.8 | $119M | 1.4M | 87.48 | |
| Madrigal Pharmaceuticals (MDGL) | 4.5 | $112M | 892k | 125.26 | |
| Merck & Co (MRK) | 4.2 | $105M | 1.3M | 83.17 | |
| Allergan | 3.6 | $90M | 618k | 146.41 | |
| Dex (DXCM) | 3.5 | $87M | 730k | 119.10 | |
| Intersect Ent | 3.3 | $83M | 2.6M | 32.15 | |
| Intuitive Surgical (ISRG) | 3.1 | $77M | 135k | 570.58 | |
| Radius Health | 3.0 | $73M | 3.7M | 19.94 | |
| Humana (HUM) | 2.8 | $69M | 258k | 266.00 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $62M | 339k | 183.95 | |
| Iqvia Holdings (IQV) | 2.3 | $58M | 403k | 143.85 | |
| Icon (ICLR) | 2.3 | $56M | 409k | 136.58 | |
| Centene Corporation (CNC) | 2.2 | $54M | 1.0M | 53.10 | |
| Horizon Pharma | 2.1 | $53M | 2.0M | 26.43 | |
| Boston Scientific Corporation (BSX) | 2.0 | $50M | 1.3M | 38.38 | |
| Medicines Company | 2.0 | $49M | 1.7M | 27.95 | |
| Bluebird Bio | 1.9 | $48M | 303k | 157.33 | |
| Stryker Corporation (SYK) | 1.9 | $47M | 240k | 197.52 | |
| Thermo Fisher Scientific (TMO) | 1.7 | $43M | 158k | 273.72 | |
| Becton, Dickinson and (BDX) | 1.7 | $41M | 165k | 249.73 | |
| Gilead Sciences (GILD) | 1.6 | $41M | 624k | 65.01 | |
| Myokardia | 1.5 | $38M | 731k | 51.99 | |
| Wright Medical Group Nv | 1.5 | $37M | 1.2M | 31.45 | |
| Clovis Oncology | 1.4 | $35M | 1.4M | 24.82 | |
| Corindus Vascular Robotics I | 1.4 | $35M | 20M | 1.74 | |
| Viewray (VRAYQ) | 1.2 | $31M | 4.2M | 7.39 | |
| CONMED Corporation (CNMD) | 1.1 | $28M | 340k | 83.18 | |
| Pacira Pharmaceuticals (PCRX) | 1.1 | $27M | 706k | 38.06 | |
| CVS Caremark Corporation (CVS) | 0.9 | $22M | 400k | 53.93 | |
| Hca Holdings (HCA) | 0.8 | $19M | 147k | 130.38 | |
| Nevro (NVRO) | 0.7 | $16M | 257k | 62.51 | |
| Irhythm Technologies (IRTC) | 0.6 | $16M | 212k | 74.96 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $11M | 1.2M | 9.51 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $10M | 747k | 13.53 | |
| Ionis Pharmaceuticals (IONS) | 0.4 | $10M | 125k | 81.17 | |
| Abbott Laboratories (ABT) | 0.4 | $9.6M | 120k | 79.94 | |
| Select Medical Holdings Corporation (SEM) | 0.3 | $8.5M | 600k | 14.09 | |
| Biohaven Pharmaceutical Holding | 0.3 | $7.8M | 152k | 51.47 | |
| Genfit S A ads (GNFT) | 0.3 | $7.8M | 325k | 24.00 | |
| Polarityte | 0.2 | $4.3M | 400k | 10.70 | |
| Cymabay Therapeutics | 0.1 | $3.0M | 225k | 13.28 | |
| Precision Biosciences Ord | 0.1 | $2.7M | 150k | 17.95 | |
| Karyopharm Therapeutics | 0.1 | $1.7M | 296k | 5.84 |
